| Name | ATR inhibitor 4 |
|---|---|
| Synonyms |
camonsertib
8-Oxabicyclo[3.2.1]octan-3-ol, 3-[6-[(3R)-3-methyl-4-morpholinyl]-1-(1H-pyrazol-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]-, (3-endo) RP-3500 (Synonyms: ATR inhibitor 4) RP-3500 Camonsertib (RP-3500) (1R,5S)-3-{6-[(3R)-3-methylmorpholin-4-yl]-1-(1H-pyrazol-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl}-8-oxabicyclo[3.2.1]octan-3-ol Camonsertib, 10 mM in DMSO (3-endo)-3-(6-((R)-3-Methylmorpholino)-1-(1H-pyrazol-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)-8-oxabicyclo[3.2.1]octan-3-ol |
| Description | ATR inhibitor 4 (compound 121) is a potent ATR inhibitor. ATR inhibitor 4 has antitumor activity[1]. |
|---|---|
| Related Catalog | |
| Target |
ATR |
| References |
[1]. Maria Koehler, et al. Use of atr inhibitors in combination with parp inhibitors. WO2021119523A1 |
| Molecular Formula | C21H26N6O3 |
|---|---|
| Molecular Weight | 410.47 |
| Storage condition | 2-8°C |